111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-61.50%
Revenue decline while USLM shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-61.50%
Gross profit decline while USLM shows 15.38% growth. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth above 1.5x USLM's 57.14%. Michael Burry would check for concerning trends.
100.00%
Operating expenses growth above 1.5x USLM's 33.33%. Michael Burry would check for inefficiency.
100.00%
Total costs growth above 1.5x USLM's 1.72%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.18%
EBITDA growth exceeding 1.5x USLM's 16.67%. David Dodd would verify competitive advantages.
209.53%
EBITDA margin growth exceeding 1.5x USLM's 16.67%. David Dodd would verify competitive advantages.
142.18%
Operating income growth while USLM declines. John Neff would investigate advantages.
209.53%
Operating margin growth while USLM declines. John Neff would investigate advantages.
-100.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.92%
Tax expense growth 50-75% of USLM's 100.00%. Bruce Berkowitz would examine efficiency.
-64.92%
Both companies show declining income. Martin Whitman would check industry conditions.
-8.88%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.